Adam Peckham-Cooper

Adam Peckham-Cooper

Auto-generated profile, based on publicly available information

Adam Peckham-Cooper

Department of General Surgery St James' Hospital, Leeds Teaching Hospitals NHS Foundation Trust Leeds UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
ASAdel Samson
Adel Samson
EWEmma J. West
Emma J. West
JCJonathan Carmichael
Jonathan Carmichael
KSKaren Scott
Karen Scott
STSamantha Turnbull
Samantha Turnbull
FCFiona Collinson
Fiona Collinson
Improving the chances of curing patients with cancer who have had surgery to remove metastatic sites of disease is a priority area for cancer research. Pexa-Vec (Pexastimogene Devacirepvec; JX-594, TG6006) is a principally immunotherapeutic oncolytic virus that has reached late-phase clinical trials. We report the results of a single-center, nonrandomized biological end point study (trial registration: EudraCT number 2012-000704-15), which builds on the success of the presurgical intravenous delivery of oncolytic viruses to tumors. Nine patients with either colorectal cancer liver metastases or metastatic melanoma were treated with a single intravenous infusion of Pexa-Vec ahead of planned surgical resection of the metastases. Grade 3 and 4 Pexa-Vec–associated side effects were lymphopaenia and neutropaenia. Pexa-Vec was peripherally carried in plasma and was not associated with peripheral blood mononuclear cells. Upon surgical resection, Pexa-Vec was found in the majority of analyzed tumors. Pexa-Vec therapy associated with IFNα secretion, chemokine induction, and resulted in transient innate and long-lived adaptive anticancer immunity. In the 2 patients with significant and complete tumor necrosis, a reduction in the peripheral T-cell receptor diversity was observed at the time of surgery. These results support the development of presurgical oncolytic vaccinia virus-based therapies to stimulate anticancer immunity and increase the chances to cure patients with cancer.

24 June 2009 in BMJ
Verified
Journal Article
Closed access
DBDaniel Beral
Daniel Beral
RARobert Adair
Robert Adair
APAdam Peckham-Cooper
Adam Peckham-Cooper
DTDamian Tolan
Damian Tolan
IBIan Botterill
Ian Botterill
Count radiolucent foam pieces used in outpatient vacuum assisted wound closure to prevent chronic sepsis

23 August 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
GHGemma L Humm
Gemma L Humm
APAdam Peckham-Cooper
Adam Peckham-Cooper
JCJessica Chang
Jessica Chang
RFRoland Fernandes
Roland Fernandes
NGNaim Fakih Gomez
Naim Fakih Gomez
LLLaurence B Lovat
Laurence B Lovat
Surgical errors are acts or omissions resulting in negative consequences and/or increased operating time. This study describes surgeon-reported errors in laparoscopic cholecystectomy. Intraoperative videos were uploaded and annotated on Touch SurgeryTM Enterprise. Participants evaluated videos for severity using a 10-point intraoperative cholecystitis grading score, and errors using Observational Clinical Human Reliability Assessment, which includes skill, consequence, and mechanism classifications. Nine videos were assessed by 8 participants (3 junior (specialist trainee (ST) 3–5), 2 senior trainees (ST6–8), and 3 consultants). Participants identified 550 errors. Positive relationships were seen between total operating time and error count (r2 = 0.284, P < 0.001), intraoperative grade score and error count (r2 = 0.578, P = 0.001), and intraoperative grade score and total operating time (r2 = 0.157, P < 0.001). Error counts differed significantly across intraoperative phases (H(6) = 47.06, P < 0.001), most frequently at dissection of the hepatocystic triangle (total 282; median 33.5 (i.q.r. 23.5–47.8, range 15–63)), ligation/division of cystic structures (total 124; median 13.5 (i.q.r. 12–19.3, range 10–26)), and gallbladder dissection (total 117; median 14.5 (i.q.r. 10.3–18.8, range 6–26)). There were no significant differences in error counts between juniors, seniors, and consultants (H(2) = 0.03, P = 0.987). Errors were classified differently. For dissection of the hepatocystic triangle, thermal injuries (50 in total) were frequently classified as executional, consequential errors; trainees classified thermal injuries as step done with excessive force, speed, depth, distance, time or rotation (29 out of 50), whereas consultants classified them as incorrect orientation (6 out of 50). For ligation/division of cystic structures, inappropriate clipping (60 errors in total), procedural errors were reported by junior trainees (6 out of 60), but not consultants. For gallbladder dissection, inappropriate dissection (20 errors in total) was reported in incorrect planes by consultants and seniors (6 out of 20), but not by juniors. Poor economy of movement (11 errors in total) was reported more by consultants (8 out of 11) than trainees (3 out of 11). This study suggests that surgical experience influences error interpretation, but the benefits for surgical training are currently unclear.

4 August 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
APA. Peckham‐Cooper
A. Peckham‐Cooper
PCPeter Coe
Peter Coe
RCR. W. Clarke
R. W. Clarke
JBJoshua Burke
Joshua Burke
MLM. J. Lee
M. J. Lee
Click on the article title to read more.

7 May 2025 in BJS Open
Verified
Journal Article
Open access
MGMatthew Gowell
Matthew Gowell
DBDaniel M Baker
Daniel M Baker
GMGreta McLachlan
Greta McLachlan
DNDavid N Naumann
David N Naumann
APAdam Peckham-Cooper
Adam Peckham-Cooper
MLMatthew J Lee
Matthew J Lee
Background: Adhesional small bowel obstruction is a common presentation to acute general surgical services. Initial management is typically conservative and includes the use of water-soluble contrast agents. Current trials assessing water-soluble contrast agents are limited by sample size and demonstrate contrasting results. The aim of this review was to systematically appraise the use of water-soluble contrast agents in adhesional small bowel obstruction. Methods: This systematic review and meta-analysis was registered with PROSPERO (CRD42024573136) and conducted in line with PRISMA guidelines. Searches of Medline, Embase and Central databases were undertaken to include randomized clinical trials reporting the use of water-soluble contrast agents in adhesional small bowel obstruction. Searches were last updated on 26 July 2024. The primary outcome was the need for operative intervention. Secondary outcomes included the rate of intestinal ischaemia, the need for bowel resection, and mortality. A random-effects meta-analysis was conducted for outcomes reported in three or more studies. Risk of bias was assessed using the Cochrane Risk-of-Bias tool, and trial methods were appraised using the PRagmatic Explanatory Continuum Indicator Summary (PRECIS-2) tool. Results: In all, 11 randomized controlled trials were included with a median sample size of 88 (range 26–242), nine of which were single-centre studies; only one study used computed tomography imaging to diagnoses adhesional small bowel obstruction. Meta-analysis revealed no significant difference in operative intervention (odds ratio 0.63, 95% confidence interval 0.39 to 1.01; P = 0.053), small bowel ischaemia, small bowel resection, or mortality. Risk of bias raised concerns in several domains. PRECIS-2 assessment showed trials were pragmatic rather than explanatory designs. Conclusion: This review does not support the use of therapeutic water-soluble contrast agents in adhesional small bowel obstruction. Further adequately powered trials are needed. Standardization of diagnostic modality and consideration of explanatory designs should be considered.

25 April 2022 in British Journal of Surgery
Verified
Journal Article
Open access
PCPpu Cds Collaborators
Ppu Cds Collaborators
SLS Lamidi
S Lamidi
KWK M Williams
K M Williams
DHDaniel Hind
Daniel Hind
APA Peckham-Cooper
A Peckham-Cooper
Andee Dzulkarnaen ZakariaAndee Dzulkarnaen Zakaria
Andee Dzulkarnaen Zakaria
Background: Perforated peptic ulcer (PPU) remains a common condition globally with significant morbidity and mortality. Previous work has demonstrated variation in reporting of patient characteristics in PPU studies, making comparison of studies and outcomes difficult. The aim of this study was to standardize the reporting of patient characteristics, by creating a core descriptor set (CDS) of important descriptors that should be consistently reported in PPU research. Methods: Candidate descriptors were identified through systematic review and stakeholder proposals. An international Delphi exercise involving three survey rounds was undertaken to obtain consensus on key patient characteristics for future research. Participants rated items on a scale of 1–9 with respect to their importance. Items meeting a predetermined threshold (rated 7–9 by over 70 per cent of stakeholders) were included in the final set and ratified at a consensus meeting. Feedback was provided between rounds to allow refinement of ratings. Results: Some 116 clinicians were recruited from 29 countries. A total of 63 descriptors were longlisted from the literature, and 27 were proposed by stakeholders. After three survey rounds and a consensus meeting, 27 descriptors were included in the CDS. These covered demographic variables and co-morbidities, risk factors for PPU, presentation and pathway factors, need for organ support, biochemical parameters, prognostic tools, perforation details, and surgical history. Conclusion: This study defines the core descriptive items for PPU research, which will allow more robust synthesis of studies.